Ledger.Open graph →
SEC Form D · filed November 18, 2025

Dualitas Therapeutics, Inc

Offering
$66.6M
Sold
$32.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Thomas Hudson · Dubai, C0DirectorForbes Huang · South San Francisco, CAExecAlicia Levey · South San Francisco, CADirectorMichael Ross · Foster City, CADirectorGreg Lazar · South San Francisco, CAExecNeil Weir · Bedford, MADirectorMark Mcdade · San Francisco, CADirectorRichard Murray · Albuquerque, NMExec · DirectorNikola Trbovic · Waltham, MADirectorThomas Hudson · SAN DIEGO, CADirectorForbes Huang · South San Francisco, CAExecAlicia Levey · South San Francisco, CADirectorMichael Ross · Chagrin Falls, OHDirectorGreg Lazar · South San Francisco, CAExecNeil Weir · Bedford, MADirectorMark Mcdade · Boston, MADirectorRichard Murray · Cambridge, MAExec · DirectorNikola Trbovic · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗